MVP-Associated Filamin A Mutations Affect FlnA-PTPN12 (PTP-PEST) Interactions

Area of Science:

• Molecular Biology
• Cardiovascular Genetics
• Cellular Mechanics

Background:

• The genetic basis of mitral valve prolapse (MVP) is known, but molecular mechanisms of mutations remain unclear.
• Filamin A (FLNA) gene mutations cause X-linked myxomatous valvular dystrophy, a form of MVP.
• The functional impact of FLNA mutations on protein interactions and cellular processes is largely unknown.

Purpose of the Study:

• To identify binding partners of Filamin A (FlnA) using its N-terminal repeats.
• To investigate the effect of MVP-associated FLNA mutations on FlnA interactions.
• To elucidate the role of the FlnA/PTPN12 interaction in the pathophysiology of FlnA-associated MVP.

Main Methods:

• Yeast two-hybrid screening to identify FlnA binding partners.
• Yeast two-hybrid trap assay, pull-down, and co-immunoprecipitation to confirm interactions.
• Analysis of FlnA mutation effects on PTPN12 substrate activation (Src, p190RhoGAP).

Main Results:

• Tyrosine phosphatase PTPN12 (PTP-PEST) was identified as a specific binding partner for FlnA repeats 1-8.
• MVP-associated FlnA mutations (G288R, P637Q, H743P) abolished the interaction between FlnA and PTPN12.
• FlnA mutations impaired the activation of PTPN12 substrates Src and p190RhoGAP.

Conclusions:

• The interaction between FlnA and PTPN12 is crucial for normal cellular function.
• Weakening of the FlnA/PTPN12 interaction by FLNA mutations may underlie FlnA-associated MVP.
• This study reveals a novel molecular mechanism in the pathogenesis of FlnA-related valvular disease.